From the pathological standpoint, estrogen and ER expression can accelerate the mitosis of ovarian cancer cells, which rely on inhibiting apoptosis and promoting cell proliferation to participate in the development of tumors. The gene discussed is ESR1; the disease is ovarian carcinoma.